$BSVN

Estes Jason E sold $125K of BSVN

Estes Jason E (Exec. Vice President; CCO) sold 2,477 shares of Bank7 Corp. (BSVN) at an average of $50.34 ($50.17–$51.25, $0.12M total) across 2 trades over 2026-08-03 to 2026-08-04.

Original reporting
SEC EDGAR · Estes Jason E
Published Aug 4, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:23 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BSVN
Neutral
medium confidence
Mentioned
$BSVN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BSVNNeutralLow
01

Why it matters

The disclosure updates the record of insider ownership and may influence short-term sentiment, but it does not change earnings, guidance, or risk factors based on the provided text.

02

Market read

Traders may note the insider sale as a sentiment datapoint, but there is no accompanying fundamental or regulatory catalyst in the text.

03

What to watch

The article does not state whether the sale was part of a broader pattern, whether options were exercised, or whether other insiders filed concurrent transactions.

Relevance 4/10Novelty 3/10Timing: Form 4 filed 2026-08-04, covering sales on 2026-08-03 to 2026-08-04.

Background

The article is an SEC Form 4 insider transaction disclosure for Bank7 Corp. (BSVN).

Company-level read

Ticker impact

$BSVNNeutralMedium confidence
Context

Bank7 Corp. insider Estes Jason E sold about 2,477 shares in open-market trades for roughly $124.7K, per a fresh Form 4 filed Aug. 4.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven and typically fades unless paired with other disclosures.

Evidence & confidence

The filing is a primary-source Form 4, but the article contains only transaction details (size, price range, post-sale holdings) without any accompanying company-specific news.

Market effects

No sector-level signal; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; absence of a stated 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • Bank7 Corp.

    Subject of the Form 4 insider sale disclosure.

  • Estes Jason E

    Exec. Vice President and CCO who sold shares in open-market transactions.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BSVNMed

Piper Sandler raises Bank7 stock price target on strong growth

Piper Sandler raised its price target for Bank7 Corp. (BSVN) to $69.00, citing strong Q3 results with 2.24% return on assets and 16.4% return on tangible common equity. The stock is near its 52-week high, up 38% year-to-date. Piper Sandler also increased its EPS estimates for 2026 and 2027, anticipating growth from the Century Bank acquisition. Bank7 reported Q3 earnings of $1.06 per share, beating estimates, but missed on revenue.

$BSVNMed

Bank7 (BSVN) Q3 2026 Earnings Call Transcript

Bank7 (BSVN) reported Q3 2026 earnings, highlighting strong deposit growth and an upcoming merger with Century in New Mexico. The merger is expected to be neutral to their net interest margin (NIM) but will provide cheaper funding. Bank7 plans to maintain its loan growth trajectory and deploy excess liquidity methodically. Century's loan portfolio will be integrated similarly to Bank7's existing strategy.

$BSVNHighAI 8/10

Bank7 Q3 2026 slides: earnings beat forecast as Century merger nears

Bank7 Corp (BSVN) reported Q3 2026 earnings of $1.06 per share, beating estimates, with revenue at $23.37M, slightly below forecasts. Stock rose 2.02% in premarket trading. The bank saw 22.3% net income growth and announced a $137M acquisition of Century Financial, expected to close November 1, 2026, adding $1.2B in deposits. Management expects EPS accretion of over 25% from the deal.

$BSVNMed

Bank7: Q3 Earnings Presentation

Bank7 reported Q3 2026 earnings with total assets of $2.01B, net income of $10.2M, and diluted EPS of $1.06. Key metrics include a 22.3% increase in net income and a 21.8% rise in EPS. The bank announced an acquisition of Century Financial for $137M, expected to close November 1, 2026, with projected EPS accretion of 25%.